Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer

18

Citations

37

References

2014

Year

Ying‐Chun Shen, Chung‐Pin Li, Chia-Jui Yen, Chiun Hsu, Yulin Lin, Zhong-Zhe Lin, Li‐Tzong Chen, Wu‐Chou Su, Yee Chao, Kun‐Huei Yeh,

Abstract

Adding low-dose everolimus to cisplatin-HDFL chemotherapy failed to increase the ORR as in a preplanned statistical assumption but may prolong progression-free survival in treatment-naïve advanced gastric cancer patients.

References

	Year	Citations

Page 1